ANAHEIM, Calif., Aug. 2, 2023 /PRNewswire/ — Histologics LLC and its Founder and CEO, Dr. Neal Lonky have been nominated for the Orange County Business Journal Innovator of the Year award for 2023. The Kylon® medical fabric, a replacement for conventional steel metal tool devices has revolutionized cervical and wound biopsy, and gentle or surgical debridement for chronic wound care. Over 1M clinical cases have been performed with this safe, sterile, single use disposable technology in the United States thus far with stellar clinical outcomes.
Per the Orange County Business Journal:
“The 2023 Innovator of the Year Awards program allows for the recognition of five innovators who are changing the status quo in OC’s community of business. There are 51 nominees for the 2023 Innovator of the Year Awards. The 2023 Innovator of the Year Awards special report which features nominee profiles and specialized advertorials from our sponsors was published on July 31, 2023. Five awards will be presented at the 2023 Innovator of the Year Awards Luncheon & Program on September 7, 2023, at the Irvine Marriott. The 2023 IOTY Awards Keynote Speaker is Kurt Busch, Co-Founder & CEO of Syntiant Corp.”
For more information regarding Histologics, the Women’s Health or Wound Care Technologies, or Dr. Lonky’s background, please contact Lily Ramos at histologicswc@gmail.com, Toll Free: 888-235-2275. Please visit our websites at www.histologics.com and www.histologicswc.com for more information or if a medical professional, to request samples.
SOURCE Histologics LLC
CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…
Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…
Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…
Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…
Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…
Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…